Lung adenocarcinoma promotion by air pollutants
2023 · Nature · 683 citations
https://doi.org/10.1038/s41586-023-05874-3
J
Jesse Boumelha
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
93
Papers
1.5K
Citations
11
h-index
11
i10-index
Jesse Boumelha is an academic researcher from Mount Sinai Hospital. The author has contributed to research in topics: Synthesis and Biological Evaluation & Cancer Immunotherapy and Biomarkers & Synthesis and biological activity. The author has an h-index of 11, co-authored 80 publications.
ORCID: 0000-0001-7635-2537Papers by this author
worksRETRACTED ARTICLE: Antibodies against endogenous retroviruses promote lung cancer immunotherapy
2023 · Nature · 245 citations
https://doi.org/10.1038/s41586-023-05771-9
Facts and Hopes on RAS Inhibitors and Cancer Immunotherapy
2023 · Clinical Cancer Research · 37 citations
https://doi.org/10.1158/1078-0432.ccr-22-3655
Cholesterol mobilization regulates dendritic cell maturation and the immunogenic response to cancer
2025 · Nature Immunology · 31 citations
https://doi.org/10.1038/s41590-024-02065-8
CRISPR–Cas9 Screening Identifies KRAS-Induced COX2 as a Driver of Immunotherapy Resistance in Lung Cancer
2024 · Cancer Research · 25 citations
https://doi.org/10.1158/0008-5472.can-23-2627
Combining RAS(ON) G12C-selective inhibitor with SHP2 inhibition sensitises lung tumours to immune checkpoint blockade
2024 · Nature Communications · 16 citations
https://doi.org/10.1038/s41467-024-52324-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat